RK

Rajni Kant Gupta

Director Director DIN 02081166
DIN 02081166 First appointment May 2003 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajni Kant Gupta

Data last updated:

Rajni Kant Gupta was a Director at Aria Biotech Private Limited (2012–2019) and Director at Biosynth Pharmaceuticals Private Limited (from 2003). The companies operate in Chemicals.

DIN 02081166
Primary Designation Director
Industry Chemicals
First Appointment 26 May 2003
Oldest Company Age 37 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aria Biotech Private Limited U24232MP2012PTC029508
Director06 Nov 20122012₹88 Lakh (FY 2020)Active
Director26 May 20031989Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biosynth Pharmaceuticals Private Limited
Aria Biotech Private Limited
Premium access

Shareholding and investment profile for Rajni Kant Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajni Kant Gupta

Rajni Kant Gupta was first appointed on 26 May 2003 as Director at Biosynth Pharmaceuticals Private Limited. The most recent appointment on record is 06 Nov 2012 at Aria Biotech Private Limited.

Rajni Kant Gupta held 2 earlier board appointments: Aria Biotech Private Limited (Director, 06 Nov 2012 to 30 Nov 2019); Biosynth Pharmaceuticals Private Limited (Director, from 26 May 2003).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available